Surgery Doctors in Shakopee, MN Accepting Medicare
4 Surgery doctors found. Showing 1 - 4
 Dr. Jayson Carl Dock, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Saint Francis Ave, Suite 100, Shakopee, MN 55379 Phone: 952-428-3535 |
 Dr. Anne Elisabeth Dietrich, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Saint Francis Ave, Suite 100, Shakopee, MN 55379 Phone: 952-428-3535 Fax: 952-428-3599 |
Dr. Michael Jon Walker, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1515 Saint Francis Ave, #100, Shakopee, MN 55379 Phone: 952-403-3535 Fax: 952-403-3599 |
Dr. Gary Micheal Jonson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 Saint Francis Ave, Suite 200, Shakopee, MN 55379 Phone: 952-993-7819 |
News Archive
Experts aim to develop noninvasive technology that accelerates learning
The adage "put your thinking caps on" might evoke visions of an elementary classroom, where a teacher has just admonished cherubic little learners about to embark on a particularly difficult academic adventure.
The Big Apple bans bad fat!
The municipal board of health for New York city has banned the use of artificial trans fats at all restaurants and food outlets in the city.
Supplement of polyunsaturated fatty acids may improve reading skills in children
Supplement of omega-3 and omega-6 fatty acids may improve reading skills of mainstream schoolchildren, according to a new study from Sahlgrenska Academy, at the University of Gothenburg, Sweden.
Study examines sleep and its impact on health and education
Whether or not you know any high school students that actually get nine hours of sleep each night, that's what federal guidelines currently prescribe. A new Brigham Young University study found that 16-18 year olds perform better academically when they shave about two hours off that recommendation.
Once-a-day dosing clinical study of udenafil for erectile dysfunction completed
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
› Verified 5 days ago
Family Medicine
Internal Medicine
Obstetrics & Gynecology
Emergency Medicine
Pediatrics
Anesthesiology
Surgery
Orthopaedic Surgery
Psychiatry & Neurology
Hospitalist